Cite
HARVARD Citation
Piccioni, D. et al. (n.d.). Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy. Neuro-oncology. 16 (6), pp. 815-822. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Piccioni, D. et al. (n.d.). Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy. Neuro-oncology. 16 (6), pp. 815-822. [Online].